Literature DB >> 24855011

Microbiome and colorectal carcinoma: insights from germ-free and conventional animal models.

Helena Tlaskalova-Hogenova1, Luca Vannucci, Klara Klimesova, Renata Stepankova, Jiri Krizan, Miloslav Kverka.   

Abstract

The mammalian microbiota plays a crucial role in the pathogenesis of many diseases. Thanks to recent advances in metagenomics, proteomics, and metabolomics, microbiome composition and metabolic activity can now be studied in detail. Results obtained by such fascinating and provocative studies would be meaningless without considering the perspective of the whole organism. Our work using gnotobiology as the major tool to unravel the mechanisms of host-microbe interaction has demonstrated the crucial role of microbiota in the initiation and progression of inflammation-associated colorectal neoplasia. Carcinogenesis in the gut is driven by the presence of potentially harmful microbes or by lack of protective ones, by the production of carcinogens generated by microbes, and by the induction of inflammation and modulation of the immune system. Here, we review these mechanisms with special emphasis on those where gnotobiology has yielded important insights.

Entities:  

Mesh:

Year:  2014        PMID: 24855011     DOI: 10.1097/PPO.0000000000000052

Source DB:  PubMed          Journal:  Cancer J        ISSN: 1528-9117            Impact factor:   3.360


  14 in total

Review 1.  The gastrointestinal microbiota and colorectal cancer.

Authors:  Temitope O Keku; Santosh Dulal; April Deveaux; Biljana Jovov; Xuesong Han
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-12-24       Impact factor: 4.052

Review 2.  Gnotobiotic mouse model's contribution to understanding host-pathogen interactions.

Authors:  Klara Kubelkova; Milota Benuchova; Hana Kozakova; Marek Sinkora; Zuzana Krocova; Jaroslav Pejchal; Ales Macela
Journal:  Cell Mol Life Sci       Date:  2016-08-20       Impact factor: 9.261

Review 3.  Moving beyond descriptive studies: harnessing metabolomics to elucidate the molecular mechanisms underpinning host-microbiome phenotypes.

Authors:  Stephanie L Bishop; Marija Drikic; Soren Wacker; Yuan Yao Chen; Anita L Kozyrskyj; Ian A Lewis
Journal:  Mucosal Immunol       Date:  2022-08-15       Impact factor: 8.701

4.  Microbiome and Colorectal Cancer.

Authors:  Ishfaq Ahmed; Shahid Umar
Journal:  Curr Colorectal Cancer Rep       Date:  2018-10-11

Review 5.  Oral Bacterial and Fungal Microbiome Impacts Colorectal Carcinogenesis.

Authors:  Klara Klimesova; Zuzana Jiraskova Zakostelska; Helena Tlaskalova-Hogenova
Journal:  Front Microbiol       Date:  2018-04-20       Impact factor: 5.640

6.  KMP01D Demonstrates Beneficial Anti-inflammatory Effects on Immune Cells: An ex vivo Preclinical Study of Patients With Colorectal Cancer.

Authors:  Martin Gasser; Reinhard Lissner; Karol Nawalaniec; Li-Li Hsiao; Ana Maria Waaga-Gasser
Journal:  Front Immunol       Date:  2020-04-30       Impact factor: 7.561

Review 7.  Selective Manipulation of the Gut Microbiota Improves Immune Status in Vertebrates.

Authors:  Ana Montalban-Arques; Peter De Schryver; Peter Bossier; Gregor Gorkiewicz; Victoriano Mulero; Delbert Monroe Gatlin; Jorge Galindo-Villegas
Journal:  Front Immunol       Date:  2015-10-09       Impact factor: 7.561

8.  Adenomatous polyposis coli genotype-dependent toll-like receptor 4 activity in colon cancer.

Authors:  Feng Wen; Yongmei Liu; Wei Wang; Meng Li; Fuchun Guo; Yaxiong Sang; Qing Qin; Yongsheng Wang; Qiu Li
Journal:  Oncotarget       Date:  2016-02-16

9.  Soy Metabolism by Gut Microbiota from Patients with Precancerous Intestinal Lesions.

Authors:  Lorenzo Polimeno; Michele Barone; Adriana Mosca; Maria Teresa Viggiani; Farahnaz Joukar; Fariborz Mansour-Ghanaei; Sara Mavaddati; Antonella Daniele; Lucantonio Debellis; Massimo Bilancia; Luigi Santacroce; Alfredo Di Leo
Journal:  Microorganisms       Date:  2020-03-25

10.  Ex Vivo Organoid Cultures Reveal the Importance of the Tumor Microenvironment for Maintenance of Colorectal Cancer Stem Cells.

Authors:  Xingru Li; Pär Larsson; Ingrid Ljuslinder; Daniel Öhlund; Robin Myte; Anna Löfgren-Burström; Carl Zingmark; Agnes Ling; Sofia Edin; Richard Palmqvist
Journal:  Cancers (Basel)       Date:  2020-04-10       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.